Siemens Healthineers Launches Accela Radiotherapy Platform at ASTRO 2026
Siemens Healthineers has introduced the Accela radiotherapy system, a new platform designed to advance cancer treatment through improved imaging and delivery. The launch, highlighted at the ASTRO 2026 conference, positions the system as a key driver for future revenue growth. Analysts at RBC Capital Markets view the platform as a significant catalyst for the company's financial performance, while Bernstein notes ongoing near-term challenges. The Accela system represents a strategic expansion for Siemens Healthineers in the competitive radiation oncology market.